Examples of such statements include statements regarding:
that Rapid FFR and Robotic PCI are significant contributions to PCI procedures and may improve safety, lesion assessment, and bring further precision to interventional procedures;
that the CorPath® System offers robotic precision that may improve clinical outcomes and protection for physicians and staff from serious occupational hazards in the cath lab;

Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
that ACIST RXi technology provides the reassurance of accurate and reliable FFR measurements and the advantages of Rapid Exchange technology and that ACIST CVi simplifies contrast injection for procedures while enhancing safety, efficiency, control and image quality; and
that the collaboration is the first step towards realizing the strong vision of how physicians and their teams should operate in the cath lab by providing innovative solutions to optimize workflow, improve safety and eventually enhance patient care.
Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are described in the sections titled "Risk Factors" in the company's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as reports on Form 8-K, including, but not limited to the following: the rate of adoption of our CorPath System and the rate of use of our cassettes; risks associated with market acceptance, including pricing and reimbursement; our ability to enforce our intellectual property rights; our need for additional funds to support our operations; our ability to manage expenses and cash flow; factors relating to engineering, regulatory, manufacturing, sales and customer service challenges; potential safety and regulatory issues that could slow or suspend our sales; and the effect of credit, financial and economic conditions on capital spending by our potential customers. Forward looking statements speak only as of the date they are made. Corindus undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date. More information is available on Corindus' website at http://www.corindus.com.
Back to HCB News